Moxetumomab Pasudotox Pivotal in relapse refractory hairy cell leukemia

Moxetumomab Pasudotox Pivotal in relapse refractory hairy cell leukemia

Annual-Meeting

1 year
85 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Michelle Dawson, MD, AstraZeneca, talks about Moxetumomab Pasudotox Pivotal in relapse refractory hairy cell leukemia at Annual Meeting 2018.
Up Next Autoplay